Auwal Magaji

Dr. Auwal Magaji

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2023 in UMYU Journal of Microbiology Research (UJMR)
Verified
Journal Article
Open access
PDF file
Auwal MagajiAuwal Magaji
Auwal Magaji
ZMZinat Mahmud
Zinat Mahmud
AMAminu Mustafa
Aminu Mustafa
Vernonia amygdalina is a plant known to contain substances with reported antimicrobial properties against various microorganisms. This study therefore, aimed at assessing the antibacterial properties of Vernonia amygdalina extract against some clinical bacterial isolates. The bacterial isolates were obtained from General hospital Azare, and the Vernonia amygdalina leaves were purchased at Azare central market. Various compounds, including saponins, glycosides, tannins, flavonoids, steroids, phenolic compounds, and alkaloids, were identified in the plant extract via phytochemical screening. Different concentrations of the V. amygdalina extract (25mg/mL, 50mg/mL, and 100mg/mL) were prepared and screened for antibacterial using disc diffusion method, revealing zones of inhibition of 7.00 mm, 9.00 mm and 4.00 mm against Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae respectively, at 100mg/ml of the extract. The MIC of the extract against Escherichia coli and Staphylococcus aureus was 25 mg/mL, whereas 50 mg/mL of the extract was found to be the minimum concentration active against Klebsiella pneumoniae. The study found that the extract exhibited modest antibacterial activity, with different minimum inhibitory concentrations for the bacterial strains.

24 March 2025 in Dutse Journal of Pure and Applied Sciences
Verified
Journal Article
Open access
PDF file
Auwal MagajiAuwal Magaji
Auwal Magaji
ZMZinat Mahnud
Zinat Mahnud
Malaria and typhoid fever are among the most prevalent infectious diseases in tropical and subtropical regions, often co-existing in a single patient and complicating diagnosis, treatment, and management. The co-infection is influenced by various socioeconomic, environmental, and behavioral factors, resulting in increased morbidity and, in severe cases, mortality. This study aimed to assess the prevalence of malaria and typhoid co-infection and identify associated risk factors among patients attending health facilities in Bauchi North, Nigeria. A total of 300 blood samples were collected from patients at Extreme Hospital, Azare, Bauchi North. Malaria diagnosis was conducted using microscopy with Giemsa-stained thick blood films, while typhoid was diagnosed using the Widal test. The overall prevalence of malaria and typhoid co-infection was 38%, with the highest rate observed among females (24%) and adults aged 25–64 years. No cases were recorded among elderly individuals aged 65 years and above. A higher prevalence was found in rural areas (25.33%) and among middle-income groups (19%). Among all risk factors examined, only the residence of the patients showed a statistically significant association with co-infection. This study highlights the substantial burden of malaria and typhoid co-infection in Bauchi North, emphasizing the role of residence as a critical risk factor. The findings highlighted the need for tailored public health interventions, particularly in rural areas, to reduce the prevalence of these co-infections.

30 March 2025 in UMYU Scientifica
Verified
Journal Article
Open access
PDF file
Auwal MagajiAuwal Magaji
Auwal Magaji
ZMZinat Mahmud
Zinat Mahmud
AYAdamu Yakubu
Adamu Yakubu
RMRilwanu Salihu Maradun
Rilwanu Salihu Maradun
SASalim Aminu
Salim Aminu
SASabiu Aminu
Sabiu Aminu
Study’s Excerpt: • The study assessed malaria prevalence and risk factors in Bauchi North, Bauchi State, Nigeria. • Microscopy detected the parasite, while structured questionnaires identified infection determinants. • Results showed a high malaria burden with variations by age and socioeconomic status. • Findings highlight the need for public health interventions targeting high-risk, vulnerable groups. • Findings can guide policymakers in malaria treatment, control, and prevention efforts. Full Abstract: Malaria remains a leading public health concern globally, particularly in sub-Saharan Africa, with Nigeria bearing a significant burden of the disease. This cross-sectional study aimed to assess malaria prevalence and associated risk factors among patients attending healthcare facilities in Bauchi North, Bauchi State, Nigeria. A total of 300 patients suspected of having malaria were enrolled, and blood samples were analyzed using microscopy of thick blood film stained with Giemsa’s stain. The presence of gametocytes, trophozoites, or schizonts, which stained dark blue, indicated positive results. Structured questionnaires were administered to collect demographic and risk factor data. The overall prevalence of malaria was 40%, with higher prevalence rates among females (27%) compared to males (13%) and among adults aged 25–64 years (24%). Rural residents (29.67%), individuals from low-income families (20.67%), and those exposed to poor housing and environmental conditions exhibited higher prevalence rates. The key risk factors assessed included residence of the patients, use of a net, and socioeconomic status, among which a history of fever within two weeks prior to the study (p = 0.006) was the only statistically significant risk factor associated with malaria at p < 0.05. Logistic regression analysis confirmed fever history as the primary predictor of malaria (COR = 0.438, 95% CI = 0.242–0.792). These findings highlighted the need for targeted malaria control interventions focusing on high-risk groups and environmental management. Strengthened public health campaigns are essential to improve awareness of the danger of malaria, its modes of transmission, infection agents, and preventive measures in underserved areas.

14 December 2025 in Science World Journal
Verified
Journal Article
Open access
PDF file
Auwal MagajiAuwal Magaji
Auwal Magaji
NKNathaniel Luka Kwarau
Nathaniel Luka Kwarau
MBMuhammad Kabir Babayo
Muhammad Kabir Babayo
ZMZinat Mahmud
Zinat Mahmud
AJAbdullahi Aliyu Jibo
Abdullahi Aliyu Jibo
AMAbubakar Musa
Abubakar Musa
Drug-resistant tuberculosis (DR-TB) remains a major public health challenge in Nigeria, especially in the northern region where weak health systems, poverty, conflict, and stigma exacerbate the problem. This review assesses the epidemiology, diagnostic landscape, treatment challenges, and health system factors influencing control of DR-TB in northern Nigeria. A systematic review on this topic was conducted on retrieved peer-reviewed articles, national reports, and other literatures from 2010 to June 2025 using PubMed, AJOL, Google Scholar, and Science Direct. Studies focusing on DR-TB epidemiology, diagnosis, treatment, and health systems in Northern Nigeria were included. Northern Nigeria shows rising DR-TB prevalence, particularly in Kano, Bauchi, and conflict-affected states. Key drivers included diagnostic delays, poor treatment adherence, drug stock-outs, and weak referral systems. While WHO-recommended diagnostic tools like GeneXpert and community-based treatment strategies are in place, access is uneven due to geographic, infrastructural, and workforce limitations. High stigma and limited community engagement further hinder detection and adherence. Health system weaknesses—such as inadequate laboratory capacity, poor funding, and weak data systems—pose significant barriers to achieving “End TB” targets. Addressing DR-TB in northern Nigeria requires a multifaceted response that goes beyond clinical care. Strengthening diagnostic infrastructure, decentralizing treatment, improving drug supply chains, enhancing community engagement, and addressing stigma are key to improving DR-TB outcomes.

20 August 2025 in Science World Journal
Verified
Journal Article
Open access
PDF file
Auwal MagajiAuwal Magaji
Auwal Magaji
IMIbrahim Musa Moi
Ibrahim Musa Moi
ZMZinat Mahmud
Zinat Mahmud
NKNathaniel Luka Kwarau
Nathaniel Luka Kwarau
MAMusa Abdullahi
Musa Abdullahi
IBIsyaku Bello
Isyaku Bello
The growing challenge of drug-resistant fungal infections necessitates the need for novel and effective therapeutic alternatives. This study investigated the phytochemical composition, antifungal activity, and acute toxicity of Vitellaria paradoxa (shea tree) leaf extracts. Aqueous and ethanolic extracts were screened for phytochemicals and tested against clinical fungal isolates using the paper disc diffusion method. Acute toxicity was assessed in mice following Organization for Economic Cooperation and Development (OECD) guideline 423. Both extracts contained alkaloids, tannins, flavonoids, steroids, and phenols; however, saponins were present only in the aqueous extract, while glycosides and carbohydrates were exclusive to the ethanolic extract. The ethanolic extract exhibited stronger antifungal activity (15.0 ± 2.0 mm to 19.0 ± 2.0 mm) than the aqueous extract (12.8 ± 0.3 mm to 15.6 ± 0.4 mm) at 200 mg/mL Microsporum canis showed the highest susceptibility, and the ethanolic extract demonstrated comparable efficacy to fluconazole against Candida albicans and Candida tropicalis. Additionally, the ethanolic extract showed lower Minimum Inhibitory Concentrations (MIC) (25 mg/mL) and MFCs (100–200 mg/mL) compared to the aqueous extract (MIC 100–200 mg/mL; limited Minimum Fungicidal Concentration (MFCs). No toxicity was observed at doses up to 4000 mg/kg in mice. These results highlight V. paradoxa ethanolic leaf extract as a safe and effective antifungal agent with therapeutic potential.

12 May 2025 in Science World Journal
Verified
Journal Article
Open access
PDF file
Auwal MagajiAuwal Magaji
Auwal Magaji
ZMZinat Mahmud
Zinat Mahmud
NKNathaniel Luka Kwarau
Nathaniel Luka Kwarau
ZIZuhairu Ibrahim
Zuhairu Ibrahim
AYAdamu Yakubu
Adamu Yakubu
SASabiu Aminu
Sabiu Aminu
Hepatitis B Virus (HBV) remains a major global health challenge, particularly in developing countries where vaccination coverage is low. This study aimed to assess the prevalence of HBV infection, knowledge, attitudes, and vaccine uptake among patients in Katagum Local Government Area Bauchi State, Nigeria. A total of 385 patients were recruited for the study. Blood samples were collected and tested for HBV surface antigen (HbsAg) using a rapid detection kit. Demographic data, vaccination status, and knowledge of HBV were obtained through structured questionnaires. Data were analyzed using descriptive and inferential statistics. The overall prevalence of HBV was 3.9%, with a higher rate in males (2.6%) compared to females (1.3%). Adults aged 25–64 years had the highest prevalence (2.6%), while no cases were recorded among individuals above 65 years. Rural residents had a higher prevalence (2.34%) than urban residents (1.56%). Vaccination coverage was 43.38%, with higher uptake among urban residents (23.38%) and males (35.06%). Marital status (p = 0.049) and place of residence (p = 0.000) were significantly associated with vaccine uptake. Knowledge of HBV was significantly linked to vaccination status (p = 0.031), as were attitudes toward the disease and its prevention (p < 0.001). The main barriers to vaccination were lack of awareness (42.20%), fear of side effects (22.94%), and negative attitudes toward vaccination (20.64%). The study highlighted a moderate HBV prevalence and suboptimal vaccination coverage in Katagum LGA, Bauchi State. There is a need for intensified awareness campaigns, improved vaccine accessibility, and targeted interventions to increase HBV vaccination rates, particularly in rural areas and among vulnerable groups.